ALEC
Price:
$1.53
Market Cap:
$169.87M
Alector, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering new treatments for neurodegenerative disorders. A key program in its pipeline is AL001, a humanized recombinant monoclonal antibody currently undergoing Phase III clinical trials. This investigational therapy targets a range of severe conditions, including frontotemporal dementia, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). Additionally, AL101 is progressing through Phase I clinical trials for general neurodegenerative diseases, with a specific focus on Alzheimer's and Parkinson's. Further bolstering its Alzheimer's portfolio, Alector is evaluating AL002 in Phase II stud...[Read more]
Industry
Biotechnology
IPO Date
2019-02-07
Stock Exchange
NASDAQ
Ticker
ALEC
According to Alector, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.25. This represents a change of 26.33% compared to the average of 4.16 of the last 4 quarters.
The mean historical Current Ratio of Alector, Inc. over the last ten years is 10.04. The current 5.25 Current Ratio has changed 5.13% with respect to the historical average. Over the past ten years (40 quarters), ALEC's Current Ratio was at its highest in in the December 2018 quarter at 22.48. The Current Ratio was at its lowest in in the March 2017 quarter at 0.
Average
10.04
Median
5.98
Minimum
3.18
Maximum
33.90
Discovering the peaks and valleys of Alector, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 164.39%
Maximum Annual Current Ratio = 33.90
Minimum Annual Increase = -74.92%
Minimum Annual Current Ratio = 3.18
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 3.83 | 12.86% |
| 2024 | 3.40 | 6.83% |
| 2023 | 3.18 | -58.94% |
| 2022 | 7.74 | 44.15% |
| 2021 | 5.37 | -13.22% |
| 2020 | 6.19 | 7.33% |
| 2019 | 5.77 | -74.34% |
| 2018 | 22.48 | 164.39% |
| 2017 | 8.50 | -74.92% |
The current Current Ratio of Alector, Inc. (ALEC) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
3.47
5-year avg
4.71
10-year avg
10.04
Alector, Inc.’s Current Ratio is less than Nkarta, Inc. (12.96), greater than Cassava Sciences, Inc. (2.19), less than Fate Therapeutics, Inc. (5.85), less than PepGen Inc. (14.98), less than Molecular Partners AG (9.42), less than Vor Biopharma Inc. (31.15), less than Corbus Pharmaceuticals Holdings, Inc. (7.92), greater than Acumen Pharmaceuticals, Inc. (4.55), less than Opus Genetics, Inc. (7.13), greater than Applied Therapeutics, Inc. (0.96),
| Company | Current Ratio | Market cap |
|---|---|---|
| 12.96 | $204.62M | |
| 2.19 | $63.77M | |
| 5.85 | $240.11M | |
| 14.98 | $101.68M | |
| 9.42 | $154.17M | |
| 31.15 | $98.42M | |
| 7.92 | $102.67M | |
| 4.55 | $143.56M | |
| 7.13 | $328.84M | |
| 0.96 | $14.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alector, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alector, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Alector, Inc.'s Current Ratio?
How is the Current Ratio calculated for Alector, Inc. (ALEC)?
What is the highest Current Ratio for Alector, Inc. (ALEC)?
What is the 3-year average Current Ratio for Alector, Inc. (ALEC)?
What is the 5-year average Current Ratio for Alector, Inc. (ALEC)?
How does the current Current Ratio for Alector, Inc. (ALEC) compare to its historical average?